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Cucurbitacins are naturally occurring tetracyclic terpenes, present in foods such as cucumber and 
pumpkin, which elicit a range of anti-tumour, anti-inflammatory and anti-atherosclerotic effects. These 
dietary compounds modulate cellular functions through a variety of mechanisms, including 
dysregulation of the actin cytoskeleton and disruption of integrin function. Integrin outside-in signalling 
and cytoskeletal rearrangements are critical for stable thrombus formation and clot retraction following 
platelet adhesion at the site of vessel damage. We investigated the effects of cucurbitacins on platelet 
function and thrombus formation using human washed platelets, platelet rich plasma and whole blood 
in in vitro platelet function assays.  
We identified potent anti-platelet and anti-thrombotic effects of cucurbitacins B,E and I in human 
platelets. Treatment of platelets with cucurbitacins resulted in attenuation of platelet aggregation and 
fibrinogen binding evoked by ADP, TRAP6, collagen and CRP-XL.  However, treatment with cucurbitacins 
did not significantly alter signalling events such as alpha granule secretion or mobilisation of 
intracellular calcium. We found that cucurbitacins potently inhibit integrin-mediated events, including 
adhesion and spreading on fibrinogen, fibronectin, collagen and laminin surfaces and cause a significant 
attenuation of clot retraction. Further investigation of cytoskeletal dynamics found treatment with 
cucurbitacins increased F actin polymerisation in a manner similar Jasplakinolide which has previously 
been shown to impair integrin activation, platelet spreading and clot retraction. The inhibitory effects 
of cucurbitacins on platelet integrin function and cytoskeletal dynamics resulted in the formation of 
highly unstable thrombi with reduced density under conditions of arterial shear. 
Our research identifies, anti-platelet and anti-thrombotic effects of dietary cucurbitacins that are linked 
to dysregulation of platelet cytoskeletal dynamics and integrin activity.   
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